12/16/2024
7:05 AM | Parikh Asit (Reporting)
Phathom Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/16/2024
7:05 AM | KARBE FRANK (Reporting)
Phathom Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/11/2024
7:05 AM | Phathom Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/12/2024
10:46 AM | BlackRock, Inc. (Filed by)
Phathom Pharmaceuticals (Subject)
| Form SC 13G | |
11/07/2024
7:05 AM | Phathom Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/05/2024
3:12 PM | Phathom Pharmaceuticals (Subject)
PRUDENTIAL FINANCIAL INC (Filed by)
PRUDENTIAL FINANCIAL INC (Filed by)
| Form SCHEDULE 13G/A | |
11/05/2024
2:32 PM | Phathom Pharmaceuticals (Subject)
PRUDENTIAL FINANCIAL INC (Filed by)
PRUDENTIAL FINANCIAL INC (Filed by)
| Form SCHEDULE 13G | |
|
11/04/2024
10:20 AM | JENNISON ASSOCIATES LLC (Filed by)
Phathom Pharmaceuticals (Subject)
| Form SC 13G | |
10/21/2024
3:11 PM | BlackRock, Inc. (Filed by)
Phathom Pharmaceuticals (Subject)
| Form SC 13G | |
08/22/2024
3:05 PM | Frazier Life Sciences Public Fund, L.P. (Filed by)
Phathom Pharmaceuticals (Subject)
| Form SC 13D/A | |
08/19/2024
4:12 PM | Phathom Pharmaceuticals (Filer)
| Form 424B5 | |
08/19/2024
4:13 PM | Phathom Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/19/2024
5:05 AM | Phathom Pharmaceuticals (Subject)
| Form FWP | |
08/08/2024
7:06 AM | Phathom Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/18/2024
7:05 AM | Phathom Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/17/2024
1:52 PM | Nabulsi Azmi (Reporting)
Phathom Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/17/2024
1:50 PM | Curran Terrie (Reporting)
Phathom Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/17/2024
1:51 PM | Henderson Molly (Reporting)
Phathom Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/06/2024
12:59 PM | Frazier Life Sciences Public Fund, L.P. (Filed by)
Phathom Pharmaceuticals (Subject)
| Form SC 13D/A | |
05/31/2024
5:37 PM | Henderson Molly (Reporting)
Phathom Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/31/2024
5:34 PM | Nabulsi Azmi (Reporting)
Phathom Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/31/2024
3:30 PM | KARBE FRANK (Reporting)
Phathom Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/24/2024
6:33 PM | KARBE FRANK (Reporting)
Phathom Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/24/2024
6:43 PM | FIELDS HEIDI (Reporting)
Phathom Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/24/2024
6:44 PM | COLA MICHAEL F (Reporting)
Phathom Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/24/2024
6:46 PM | Parikh Asit (Reporting)
Phathom Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/24/2024
6:47 PM | Phathom Pharmaceuticals (Issuer)
Topper James N (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/24/2024
6:14 PM | Phathom Pharmaceuticals (Issuer)
Socks David A (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/24/2024
6:18 PM | Phathom Pharmaceuticals (Issuer)
Stenhouse Mark (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/24/2024
3:03 PM | Phathom Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/09/2024
7:05 AM | Phathom Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/10/2024
3:30 PM | Henderson Molly (Reporting)
Phathom Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/10/2024
5:10 AM | Phathom Pharmaceuticals (Subject)
TAKEDA PHARMACEUTICAL CO LTD (Filed by)
| Form SC 13D/A | |
04/01/2024
5:15 AM | Phathom Pharmaceuticals (Subject)
TAKEDA PHARMACEUTICAL CO LTD (Filed by)
| Form SC 13D/A | |
03/26/2024
3:05 PM | Curran Terrie (Reporting)
Phathom Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/07/2024
7:06 AM | Phathom Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/13/2024
7:05 AM | Phathom Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/26/2024
3:00 PM | Phathom Pharmaceuticals (Subject)
| Form SC 13G/A | |
01/26/2024
3:00 PM | Medicxi Growth I LP (Filed by)
Phathom Pharmaceuticals (Subject)
| Form SC 13G/A | |
01/25/2024
5:13 AM | Phathom Pharmaceuticals (Issuer)
TAKEDA PHARMACEUTICAL CO LTD (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/25/2024
5:11 AM | Phathom Pharmaceuticals (Subject)
TAKEDA PHARMACEUTICAL CO LTD (Filed by)
| Form SC 13D/A | |
Do this Before Elon’s Reveal on January 22nd (Ad) Elon’s newest tech could pay you an extra $30,000 a year — while you sleep.
It’s smaller than a quarter but designed to power a $9 trillion AI revolution.
And I’ve identified a little-known supplier Elon is depending on to make it all happen. I urge you to watch this video now. |
01/22/2024
7:19 PM | Curran Terrie (Reporting)
Phathom Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/22/2024
7:21 PM | Nabulsi Azmi (Reporting)
Phathom Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/22/2024
7:22 PM | Henderson Molly (Reporting)
Phathom Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
